Veterinary Drugs Compounding Market is Anticipated to Display Remarkable Growth Owing to Rising Prevalence of Zoonotic Diseases
Veterinary drugs compounding involves blending, mixing or altering ingredients in response to a veterinarian's prescription to create a medication tailored to an individual patient's unique needs. Veterinarians may compound medications for animals that need specialized dosages, forms or flavors not commercially available. For example, if a dog needs medication but cannot swallow pills, a compounding pharmacist can alter the formulation to make it possible for the medication to be given as a liquid, cream, or flavor the product to make it more palatable. The global veterinary drugs compounding market offers tailor-made medications for pets suffering from various medical conditions.
The global Veterinary Drugs Compounding Market is estimated to be valued at US$ 1512.63 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
One of the key drivers for the veterinary drugs compounding market growth is the rising prevalence of zoonotic diseases. Zoonotic diseases are infectious diseases transmissible between animals and humans. According to WHO, nearly 75% of emerging infectious diseases affecting humans are zoonotic. Greater contact between humans, livestock and companion animals has increased the risk of disease transmission, like rabies and avian influenza. Veterinary pharmacists play a crucial role in preparing tailor-made medications for effective treatment of zoonotic diseases in companion animals. Moreover, the lack of commercially available formulations suitable for some animals also necessitates compounding of drugs by pharmacists. This has significantly driven the demand for customized medications in the global veterinary drugs compounding market.
SWOT Analysis
Strength: The veterinary drugs compounding market has strong growth potential owing to rising animal healthcare awareness. With rising pet ownership, demand for custom veterinary medications is growing. Veterinary compounding services offer flexibility to treat animals with complex needs. Personalized treatment options cater to niche medical cases.
Weakness: Compounded medications incur higher costs than store-bought drugs. Lack of standardized regulation poses quality and safety concerns in some regions. Shortages of raw materials disrupt production schedules for compounders.
Opportunity: Rapid pet adoption during the pandemic has boosted long-term demand outlook. Untapped rural markets in developing nations present expansion opportunities. Technological advancements may enhance safety, precision and scalability of compounding operations.
Threats: Strict regulations by authorities aim to curb inconsistent quality standards. Generic drugs pose pricing competition upon patent expiries. Supply chain disruptions post pandemic may impact raw material procurement.
Key Takeaways
The Global Veterinary Drugs Compounding Market Growth is expected to witness high over the forecast period. The global Veterinary Drugs Compounding Market is estimated to be valued at US$ 1512.63 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031.
The North American region currently dominates the market owing to rising pet healthcare expenditure and advanced compounding facilities. Countries like the US and Canada are major revenue generators. The Asia Pacific region is expected to grow at the fastest pace during the forecast period. Rapidly improving pet care standards and rising number of vet clinics and hospitals are driving the APAC veterinary drugs compounding market. China, India, Japan and South Korea represent high potential markets.
Key players operating in the veterinary drugs compounding market are BASF SE, Huntsman Corporation, The Dow Chemical Company, 3M Company, DuPont, Aditya Birla Chemicals Ltd (Thailand), Momentive Specialty Chemicals Inc, Nan Ya Plastics Corporation, Kukdo Chemical Ltd., and NAMA Chemicals. These companies focus on expanding their veterinary compounding product portfolios and strengthening global distribution networks.
Explore more information on this topic, Please visit -
Explore more trending article related this topic -
https://www.ukwebwire.com/cancer-biomarkers-market-size-and-trends-analysis/